相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Clinical Progress of PD-1/L1 Inhibitors in Breast Cancer Immunotherapy
Fei Chen et al.
FRONTIERS IN ONCOLOGY (2022)
Thermal Ablation as an Alternative for Surgical Resection of Small (≤ 2 cm) Breast Cancers: A Meta-Analysis
Elles M. F. van de Voort et al.
CLINICAL BREAST CANCER (2021)
Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection
Alexa C. Glencer et al.
NPJ BREAST CANCER (2021)
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Photodynamic Therapy in Primary Breast Cancer
Shramana M. Banerjee et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors
Kensuke Kaneko et al.
COMMUNICATIONS BIOLOGY (2020)
Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer
Erika J. Crosby et al.
CLINICAL CANCER RESEARCH (2020)
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Javier Cortes et al.
LANCET (2020)
Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era Current and Future Molecular-Based Testing
Kevin Shee et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer
Jia-Min B. Pang et al.
MODERN PATHOLOGY (2017)
In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior
Takuya Osada et al.
CLINICAL CANCER RESEARCH (2017)
A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo
Lauren B. Crowe et al.
ACS CHEMICAL BIOLOGY (2017)
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment
J. Turpin et al.
ONCOGENE (2016)
Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer
Robert Lesurf et al.
CELL REPORTS (2016)
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma in Situ
Mathias Worni et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma in Situ
Mathias Worni et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
Steven A. Narod et al.
JAMA ONCOLOGY (2015)
PI3K Pathway Activation in High-Grade Ductal Carcinoma in Situ-Implications for Progression to Invasive Breast Carcinoma
Rita A. Sakr et al.
CLINICAL CANCER RESEARCH (2014)
Optical and Radioiodinated Tethered Hsp90 Inhibitors Reveal Selective Internalization of Ectopic Hsp90 in Malignant Breast Tumor Cells
Jared J. Barrott et al.
CHEMISTRY & BIOLOGY (2013)
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer
Qing Cheng et al.
BREAST CANCER RESEARCH (2012)
Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities
Malini Olivo et al.
PHARMACEUTICALS (2010)
Elevated expression of nuclear Hsp90 in invasive breast tumors
Malissa C. Diehl et al.
CANCER BIOLOGY & THERAPY (2009)
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
Fariba Behbod et al.
BREAST CANCER RESEARCH (2009)
Photodynamic therapy for treatment of solid tumors - Potential and technical challenges
Zheng Huang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2008)
Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts
Larry R. Tait et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
The natural history of ductal carcinoma in situ of the breast:: a review
B Erbas et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up
ME Sanders et al.
CANCER (2005)
Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy - Results from the Nurses' Health Study
LC Collins et al.
CANCER (2005)
Ablative approaches to the minimally invasive treatment of breast cancer
DM Agnese et al.
CANCER JOURNAL (2005)
Overdiagnosis and overtreatment of breast cancer - Rates of ductal carcinoma in situ: a US perspective
AS Kumar et al.
BREAST CANCER RESEARCH (2005)
The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast - A study of a large cohort of patients treated with surgery alone
DB Cornfield et al.
CANCER (2004)